Trial Profile
Effect of Belimumab on the Frequency of Flares in Patients with Refractory SLE: Data from Clinical Practice Setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Belimumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 26 Aug 2015 New trial record